US Food and Drug Administration (FDA)

General

Country:	Americas > Northern America > United States of America
Policymaker type:	Funder and research organisation
Policymaker name:	US Food and Drug Administration (FDA)
Policymaker URL:	http://www.fda.gov/
Policy adoption date:	22 August 2013
Source of policy:	Administrative/management decision

Policy Terms

Deposit of item:	Unspecified
Locus of deposit:	Not Specified
Date of deposit:	Not Specified
Content types specified under the mandate:	Not Specified
Journal article version to be deposited:	Not Specified
Can deposit be waived?:	Not specified
Making deposited item Open Access:	Not Mentioned
Can making the deposited item Open Access be waived?:	Not Specified
Date deposit to be made Open Access:	Not Mentioned

Other Details

Is deposit a precondition for research evaluation (the 'Liège/HEFCE Model')?:	Not Specified
Rights holding:	Not Mentioned
Can rights retention be waived?:	Not Applicable
Can author waive giving permission to make the article Open Access?:	Not specified
Policy's permitted embargo length for science, technology and medicine:	Not Specified
Policy's permitted embargo length for humanities and social sciences:	Not Specified
Can maximal allowable embargo length be waived?:	Not Applicable
Open licensing conditions:	Not specified
Gold OA publishing option:	Not Specified
Funding for APCs where charged by journals:	Not Mentioned

Added by (partner): EOS
URI: https://roarmap.eprints.org/id/eprint/523

Actions (login required)

View Item